15.09.2014 Views

Clinics and Other Outpatient Facility Services Handbook - TMHP

Clinics and Other Outpatient Facility Services Handbook - TMHP

Clinics and Other Outpatient Facility Services Handbook - TMHP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 2 - JANUARY 2013<br />

• Insulin<br />

• Digoxin—procedure code J1160<br />

• Norepinephrine bitartrate<br />

• Mannitol—procedure code J2150<br />

• Procaine<br />

• Protamine—procedure code J2720<br />

• Saline—procedure code A4216 or A4217<br />

• Hydrocortisone sodium succinate—procedure code J1720<br />

• Verapamil<br />

Medically necessary drugs that are not included in the composite rate may be separately reimbursed<br />

when provided by <strong>and</strong> administered in the dialysis facility by facility staff. Staff time <strong>and</strong> supplies used<br />

to administer the drugs are included in the composite rate. Examples include, but are not limited to, the<br />

following:<br />

• Antibiotics, except when prescribed for clients to treat infections or peritonitis related to peritoneal<br />

dialysis<br />

• Hematinics<br />

• Anabolics<br />

• Muscle relaxants<br />

• Analgesics<br />

• Sedatives<br />

• Tranquilizers<br />

• Erythropoietin<br />

• Thrombolytics used to declot central venous catheters<br />

• Intravenous levocarnitine (procedure code J1955), for ESRD clients who have been on dialysis for a<br />

minimum of three months with one of the following indications (All other indications for levocarnitine<br />

are not covered.):<br />

• Carnitine deficiency, defined as a plasma free carnitine level less than 40 micromoles per liter.<br />

• Signs <strong>and</strong> symptoms of erythropoietin-resistant anemia that has not responded to st<strong>and</strong>ard<br />

erythropoietin with iron replacement, <strong>and</strong> for which other causes have been investigated <strong>and</strong><br />

adequately treated.<br />

• Hypotension on hemodialysis that interferes with delivery of the intended dialysis despite application<br />

of usual measures deemed appropriate (e.g., fluid management) (such episodes of<br />

hypotension must have occurred during at least two dialysis treatments in a 30-day period).<br />

Note: Continued use of levocarnitine is not covered if improvement has not been demonstrated<br />

within six months of the initiation of treatment.<br />

The ordering physician must maintain documentation in the client’s medical record to support medical<br />

necessity.<br />

OP-24<br />

CPT ONLY - COPYRIGHT 2012 AMERICAN MEDICAL ASSOCIATION. ALL RIGHTS RESERVED.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!